Published in J Neurochem on December 01, 2002
Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J (2007) 2.27
The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem (2009) 1.27
The role of the cellular prion protein in the immune system. Clin Exp Immunol (2006) 1.09
Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells. J Neurochem (2006) 1.09
Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem (2013) 1.01
The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein. J Biol Chem (2011) 0.93
Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle. J Biol Chem (2012) 0.88
Gene expression profile following stable expression of the cellular prion protein. Cell Mol Neurobiol (2004) 0.86
Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol (2006) 0.85
Potential roles for prions and protein-only inheritance in cancer. Cancer Metastasis Rev (2012) 0.82
Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease. World J Gastroenterol (2005) 0.81
Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function. Immunology (2013) 0.79
Coagulation factor VII is regulated by androgen receptor in breast cancer. Exp Cell Res (2014) 0.78
Trafficking of PrPc to mitochondrial raft-like microdomains during cell apoptosis. Prion (2012) 0.78
Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy. BMC Genomics (2009) 0.76
Physiological Functions of the Cellular Prion Protein. Front Mol Biosci (2017) 0.75
Cellular prion protein mediates early apoptotic proteome alternation and phospho-modification in human neuroblastoma cells. Cell Death Dis (2017) 0.75
The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules. Front Mol Neurosci (2017) 0.75
Intraneuronal Abeta42 accumulation in human brain. Am J Pathol (2000) 3.83
Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem (1999) 3.20
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A (1999) 2.82
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem (1985) 2.22
Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts. Nat Cell Biol (2001) 2.22
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med (1998) 2.20
Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol (2000) 2.18
Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J Biol Chem (2001) 2.11
Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A (1999) 1.99
Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp. J Virol (2001) 1.86
Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med (1999) 1.82
The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem (2001) 1.76
Conformational flexibility of the acetylcholinesterase tetramer suggested by x-ray crystallography. J Biol Chem (1999) 1.72
Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem (1993) 1.65
PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nat Med (2004) 1.63
Immunohistochemical features of PrP(d) accumulation in natural and experimental goat transmissible spongiform encephalopathies. J Comp Pathol (2006) 1.45
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am J Pathol (2000) 1.42
New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nat Cell Biol (2001) 1.40
Competitive enzyme immunoassay with monoclonal antibody for homovanillic acid measurement in human urine samples. Clin Chem (1997) 1.39
Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet (2001) 1.33
Construction and characterization of a sheep BAC library of three genome equivalents. Mamm Genome (1999) 1.28
Mechanisms of illegitimate recombination. Gene (1993) 1.27
Isolation of a dnaE mutation which enhances RecA-independent homologous recombination in the Escherichia coli chromosome. Mol Microbiol (1997) 1.26
Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann Neurol (1998) 1.23
New insight into abnormal prion protein using monoclonal antibodies. Biochem Biophys Res Commun (1999) 1.23
A cell line infectible by prion strains from different species. J Gen Virol (2008) 1.21
A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience (2002) 1.20
Preferential labeling of alpha-amino N-terminal groups in peptides by biotin: application to the detection of specific anti-peptide antibodies by enzyme immunoassays. J Immunol Methods (1996) 1.19
Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 1.18
Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli. J Biol Chem (2000) 1.18
Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene. Biochem Biophys Res Commun (1985) 1.17
The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem (2001) 1.16
Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. Immunology (1991) 1.16
Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol (1990) 1.15
Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes. J Biol Chem (1986) 1.14
Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ (2010) 1.13
Enzyme immunoassays of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate using acetylcholinesterase. Anal Chem (1989) 1.12
Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis (2000) 1.11
Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem (2000) 1.11
Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1998) 1.11
Screening slaughtered cattle for BSE. Nature (2001) 1.09
Cellular prion protein status in sheep: tissue-specific biochemical signatures. J Gen Virol (2001) 1.09
Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells. Neurosci Lett (2000) 1.09
Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum. Eur J Biochem (1988) 1.08
Molecular architecture of acetylcholinesterase collagen-tailed forms; construction of a glycolipid-tailed tetramer. EMBO J (1992) 1.05
Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1. J Neurosci (2000) 1.04
Pharmacology and biochemistry of neurotensin receptors. Rev Clin Basic Pharm (1987) 1.04
Two-site enzyme immunometric assays for determination of native and denatured beta-lactoglobulin. J Immunol Methods (1998) 1.04
Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. Proc Natl Acad Sci U S A (2000) 1.03
Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J Neurochem (2001) 1.02
Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochim Biophys Acta (1995) 1.02
Evaluation of a high IgE-responder mouse model of allergy to bovine beta-lactoglobulin (BLG): development of sandwich immunoassays for total and allergen-specific IgE, IgG1 and IgG2a in BLG-sensitized mice. J Immunol Methods (2000) 1.02
An immunological study of rat acetylcholinesterase: comparison with acetylcholinesterases from other vertebrates. J Neurochem (1984) 1.01
Crystal-neutrophil interactions lead to interleukin-1 synthesis. Agents Actions (1991) 1.01
Efficient and specific down-regulation of prion protein expression by RNAi. Biochem Biophys Res Commun (2003) 1.01
Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom (2001) 1.00
Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem Biophys Res Commun (1987) 1.00
S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. Biochem Biophys Res Commun (1999) 0.97
Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem (1997) 0.96
Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum. Br J Pharmacol (1994) 0.96
Monoclonal antibodies allow precipitation of esterasic but not peptidasic activities associated with butyrylcholinesterase. J Neurochem (1990) 0.96
The role of the preserved sequences of Dam methylase. Nucleic Acids Res (1993) 0.95
Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase. J Neurochem (1984) 0.95
Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's beta-amyloid precursor protein: different control of early and late events by the proteasome. J Neurochem (1997) 0.94
Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. Biochem Biophys Res Commun (1998) 0.94
Existence of an inactive pool of acetylcholinesterase in chicken brain. Proc Natl Acad Sci U S A (1993) 0.93
Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles. Neurobiol Dis (2000) 0.93
Immunometric assay of low molecular weight haptens containing primary amino groups. Anal Chem (1994) 0.93
An immunoglobulin M monoclonal antibody, recognizing a subset of acetylcholinesterase molecules from electric organs of Electrophorus and Torpedo, belongs to the HNK-1 anti-carbohydrate family. J Neurochem (1987) 0.93
Examination of the role of endopeptidase 3.4.24.15 in A beta secretion by human transfected cells. Br J Pharmacol (1997) 0.92
Specific inhibition of endopeptidase 24.16 by dipeptides. Eur J Biochem (1991) 0.92
Colocalization of neurotensin receptors and of the neurotensin-degrading enzyme endopeptidase 24-16 in primary cultures of neurons. J Neurosci (1990) 0.92
A general method allowing the design of oligonucleotide primers to amplify the variable regions from immunoglobulin cDNA. J Immunol Methods (2003) 0.91
A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. J Immunol Methods (1999) 0.91
Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry. J Biol Chem (1995) 0.91
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. Ann Oncol (2007) 0.91
Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes. J Neurosci (1996) 0.90
The binding sites of inhibitory monoclonal antibodies on acetylcholinesterase. Identification of a novel regulatory site at the putative "back door". J Biol Chem (1999) 0.90
Vascular and parenchymal Abeta deposition in the aging dog: correlation with behavior. Neurobiol Aging (2000) 0.90
Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase. J Neurochem (1985) 0.90
Regulation of cyclic GMP levels by neurotensin in neuroblastoma clone N1E115. Biochem Biophys Res Commun (1985) 0.90
Immunolocalization of the cellular prion protein in normal brain. Microsc Res Tech (2000) 0.89
Protein kinase A phosphorylation of the proteasome: a contribution to the alpha-secretase pathway in human cells. J Neurochem (1996) 0.89
Synthesis in vitro of precursors of the catalytic subunits of acetylcholinesterase from Torpedo marmorata and Electrophorus electricus. Eur J Biochem (1984) 0.89
Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptide Abeta42 in late compartments of the constitutive secretory pathway. J Neurochem (2000) 0.89
Human platelet antigen 3 (HPA-3): localization of the determinant of the alloantibody Lek(a) (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates. Thromb Haemost (1993) 0.88
Cathepsin D displays in vitro beta-secretase-like specificity. Brain Res (1997) 0.87
Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization. Biochim Biophys Acta (1997) 0.87
Monoclonal antibodies against acetylcholinesterase from electric organs of Electrophorus and Torpedo. Biochimie (1987) 0.87
JLK isocoumarin inhibitors: selective gamma-secretase inhibitors that do not interfere with notch pathway in vitro or in vivo. J Neurosci Res (2003) 0.86
Biologically active interleukin 1 in human eccrine sweat: site-dependent variations in alpha/beta ratios and stress-induced increased excretion. Cytokine (1990) 0.86
Isolation of high-molecular-weight DNA from eukaryotic cells by formamide treatment and dialysis. Anal Biochem (1987) 0.86
Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases. J Neurochem (1983) 0.86